The immuno-oncology race: myths and emerging realities

Nat Rev Drug Discov. 2017 Feb 2;16(2):83-84. doi: 10.1038/nrd.2016.279.

Authors

Stephen Cavnar¹, Pedro Valencia², Jesse Brock¹, Judith Wallenstein³, Valery Panier¹

Affiliations

¹ The Boston Consulting Group, Exchange Place, Boston, Massachusetts 02109, USA.
² The Boston Consulting Group, 600 Brickell Avenue, Miami, Florida 33131, USA.
³ The Boston Consulting Group, Ludwigstraße 21, Munich 80539, Germany.

PMID: 28148948
DOI: 10.1038/nrd.2016.279

No abstract available

MeSH terms

Allergy and Immunology
Antineoplastic Agents / immunology*
Antineoplastic Agents / therapeutic use*
Humans
Medical Oncology / methods*
Neoplasms / drug therapy*
Neoplasms / immunology*

Substances

Antineoplastic Agents